However, in women with hormone receptor positive disease, transplantation of ovarian tissue may—to a greater extent than cryopreserved oocytes—interfere with the aim of ovarian function suppression to improve breast cancer outcome. This evidence concerns the gene NR4A1 and breast cancer.